Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CTWOCOTWO ADVISORS PHYSICAL EUROPEAN CARBON ALLOWANCE TRUST

NYSE · CIK 0001958928
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6199 Finance Services
FY end1130
XBRL facts59

Identity from submissions API

NameCOTWO ADVISORS PHYSICAL EUROPEAN CARBON ALLOWANCE TRUST
CIK0001958928
TickersCTWO
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6199 Finance Services
EIN920604477
LEI—
Fiscal year end1130
State of incorporationDE DE
Phone203-731-7675
Website—
Investor website—
Owner org02 Finance
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
140 ELM STREET
SUITE 6
NEW CANAAN
CT
06840
CT
Mailing address
140 ELM STREET
SUITE 6
NEW CANAAN
CT
06840
CT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

36 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-10-09 10-Q QUARTERLY REPORT 0001213900-26-108305 001-42643 261451722 34 2528649 1 1
2026-07-06 10-Q QUARTERLY REPORT 0001213900-26-075156 001-42643 261153938 34 2505075 1 1
2026-04-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001260 333-271910 26881144 33 1899
2026-04-21 424B3 PROSPECTUS 0001213900-26-046265 333-271910 26880591 33 6088786
2026-04-15 10-Q QUARTERLY REPORT 0001213900-26-044130 001-42643 26864817 34 2384933 1 1
2026-03-27 POS AM REGISTRATION STATEMENT 0001213900-26-035715 333-271910 26808602 33 6293014
2026-03-02 10-K ANNUAL REPORT 0001213900-26-021883 001-42643 26702906 34 3324423 1 1
2026-02-27 424I PROSPECTUS SUPPLEMENT 0001213900-26-021381 333-271910 26698655 33 146226 1 1
2025-10-15 10-Q QUARTERLY REPORT 0001213900-25-099117 001-42643 251394713 34 2672845 1 1
2025-07-15 10-Q QUARTERLY REPORT 0001213900-25-064133 001-42643 251124092 34 1727862 1 1
2025-06-17 CERT NYSE ARCA CERTIFICATION 0001143362-25-000182 001-42643 251052919 34 37246
2025-06-17 424B3 PROSPECTUS 0001213900-25-055017 333-271910 251052294 33 5428437
2025-05-12 8-A12B FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES 0001213900-25-041860 001-42643 25933600 34 21993
2025-05-02 FWP FREE WRITING PROSPECTUS 0001213900-25-038956 333-271910 25907441 34 9700
2025-04-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001274 333-271910 25890598 33 1886
2025-04-29 424B3 PROSPECTUS 0001213900-25-036838 333-271910 25888385 33 5428328
2025-04-25 CORRESP filename1.htm 0001213900-25-035519 8199
2025-04-07 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001213900-25-029102 333-271910 25816286 33 5882482
2025-04-04 CORRESP filename1.htm 0001213900-25-029103 36528
2025-02-18 UPLOAD filename1.pdf 0000000000-25-001817 377-06546 50487
2025-01-27 S-1/A REGISTRATION STATEMENT 0001213900-25-006645 333-271910 25555650 33 3441304
2025-01-24 CORRESP filename1.htm 0001213900-25-006648 35355
2024-05-09 UPLOAD filename1.pdf 0000000000-24-005286 377-06546 46750
2024-04-04 CORRESP filename1.htm 0001213900-24-030503 50288
2024-04-04 S-1/A REGISTRATION STATEMENT 0001213900-24-030499 333-271910 24824134 33 2855253
2024-02-23 UPLOAD filename1.pdf 0000000000-24-002054 377-06546 65753
2024-01-16 CORRESP filename1.htm 0001213900-24-003817 45736
2024-01-16 S-1/A REGISTRATION STATEMENT 0001213900-24-003814 333-271910 24536177 33 3634582
2023-06-28 UPLOAD filename1.pdf 0000000000-23-006877 377-06546 52391
2023-05-12 CORRESP filename1.htm 0001213900-23-039143 82258
2023-05-12 S-1 REGISTRATION STATEMENT 0001213900-23-039140 333-271910 23917213 33 2359558
2023-03-30 UPLOAD filename1.pdf 0000000000-23-003207 377-06546 56965
2023-03-13 DRSLTR filename1.htm 0001213900-23-019638 100336
2023-03-13 DRS/A filename1.htm 0001213900-23-019637 377-06546 23728334 33 2515707
2023-02-03 UPLOAD filename1.pdf 0000000000-23-001152 377-06546 69667
2023-01-09 DRS filename1.htm 0001213900-23-001467 377-06546 23516159 33 1722699

Latest XBRL company facts

One latest value per concept from companyfacts (59 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 100,000 2026-10-09 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
dei EntityPublicFloat Entity Public Float USD 1.74M 2025-11-30 2025 FY 10-K 2026-03-02 0001213900-26-021883
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 1,254 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap Assets Assets USD 1.89M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap AssetsNet Net Assets USD 1.89M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 16,816 2026-02-28 2026 Q1 10-Q 2026-04-15 0001213900-26-044130
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 19,250 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -1,247 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2025-11-30 2025 FY 10-K 2026-03-02 0001213900-26-021883
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 100,000 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 100,000 2025-11-30 2025 FY 10-K 2026-03-02 0001213900-26-021883
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.26 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD -9 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap ForeignCurrencyTransactionGainLossRealizedAfterTax ForeignCurrencyTransactionGainLossRealizedAfterTax USD 382 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -15,968 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -8,903 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1,666 2025-04-29 2025-08-31 2025 Q3 10-Q 2025-10-15 0001213900-25-099117
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -7 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap IncreaseDecreaseInManagementFeePayable IncreaseDecreaseInManagementFeePayable USD 49 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -26,165 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 73 2025-04-29 2025-08-31 2025 Q3 10-Q 2025-10-15 0001213900-25-099117
us-gaap InterestReceivable Interest Receivable USD 61 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyAverageNetAssets InvestmentCompanyAverageNetAssets USD 1.80M 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyExpenseRatioAfterIncentiveAllocation Investment Company, Expense Ratio after Incentive Allocation pure 0.008 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyGainLossOnInKindRedemption Investment Company, Gain (Loss) on in-kind Redemption USD 28,146 2025-06-17 2025-11-30 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyIncreaseDecreaseFromShareTransaction InvestmentCompanyIncreaseDecreaseFromShareTransaction USD 2.54M 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare Investment Company, Investment Income (Loss) from Operations, Per Share USD/shares -0.1 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure -0.008 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyMarketValuePerShare InvestmentCompanyMarketValuePerShare USD/shares 18.65 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease Investment Company, Net Asset Value Per Share, Period Increase (Decrease) USD/shares -0.26 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure -0.014 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyTotalReturnMarketValue InvestmentCompanyTotalReturnMarketValue pure -0.024 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare USD/shares -0.16 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 457 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 0 2025-05-31 2025 Q2 10-Q 2025-07-15 0001213900-25-064133
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 1.88M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap Liabilities Liabilities USD 1,254 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 18.94 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 2.54M 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1,247 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -26,165 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap NetInvestmentIncome Net Investment Income USD -10,197 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap OperatingExpenses Operating Expenses USD 10,654 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -10,197 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 2.54M 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 391 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap SharesOutstanding Shares, Outstanding shares 150,000 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap SponsorFees Sponsor Fees USD 10,654 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.89M 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD 2.54M 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 150,000 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 150,000 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.54M 2025-06-17 2025-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap StockRedeemedOrCalledDuringPeriodShares Stock Redeemed or Called During Period, Shares shares 50,000 2025-04-29 2025-11-30 2025 FY 10-K 2026-03-02 0001213900-26-021883
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 879,140 2025-04-29 2025-11-30 2025 FY 10-K 2026-03-02 0001213900-26-021883
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -16,350 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -16,350 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 100,000 2025-12-01 2026-08-31 2026 Q3 10-Q 2026-10-09 0001213900-26-108305

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →